MAP Pharmaceuticals Inc. (MAPP) announced after the close Tuesday that it agreed to be acquired by Allergan Inc. (AGN) for $25.00 per share. The acquisition is expected to close late in the first quarter or in the second quarter of 2013.
MAP Pharmaceuticals gapped open sharply higher Wednesday, but traded in a narrow range throughout the session. Shares finished up by 9.13 at $24.71 on the highest volume of the year. The stock leaped to a new high for the year.
For comments and feedback contact: editorial@rttnews.com
Business News
June 05, 2026 16:18 ET A busy week for economic news flow saw a slew of reports being released that reflected the trends in the U.S. labor market. In Europe, economic growth and inflation data gained attention as the European Central Bank and Bank of England head for policy session later in the month. In Asia, the monetary policy session of the Indian central bank was in focus as the country, a major oil importer, reels under the pressures of a weaker rupee and rising inflation.